🇺🇸 FDA
Pipeline program

NUT01

NUT-022/PSC

Phase 3 small_molecule active

Quick answer

NUT01 for Primary Sclerosing Cholangitis (PSC) is a Phase 3 program (small_molecule) at Dr. Falk Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Dr. Falk Pharma GmbH
Indication
Primary Sclerosing Cholangitis (PSC)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials